Insights

Opinion pieces from the team, and uses cases covering private markets, infrastructure investment, climate change, social risk, and more.

Featured image for “Did Sanofi sell Opella at the right price? A no headache solution to the Doliprane valuation”

Did Sanofi sell Opella at the right price? A no headache solution to the Doliprane valuation

Nov. 05, 2024
The sale of 50% of Opella to CD&R by Sanofi in October 2024 was the largest buyout in Europe this year and also the opportunity for last minute intrigue and political drama of which only the French have the secret. After several increases of the bid price, including an 11th hour attempt by PAI to outbid CD&R by a meagre
Featured image for “Buy, Sell or Hold? Is Private Equity Cheaper Now?”

Buy, Sell or Hold? Is Private Equity Cheaper Now?

Oct. 31, 2024
Higher interest rates, a sluggish exit environment, reduced distributions, and extended fundraising periods have created a challenging backdrop for private equity valuations. These factors have contributed to putting downward pressure on valuations. Despite the headwinds facing private equity valuations, the current market presents compelling opportunities for discerning investors who can leverage granular data to identify undervalued assets. In a new
Featured image for “How Risky is Private Equity? The Case of Manufacturing and Natural Resources Sectors in Europe”

How Risky is Private Equity? The Case of Manufacturing and Natural Resources Sectors in Europe

Oct. 10, 2024
Private equity investments offer high returns in exchange for taking a certain level of risk. These risks result first and foremost in considerable return dispersion and sometimes, despite the long-term investment horizon, in exits in less favourable conditions than anticipated by investors. Private companies can also go bankrupt, but they are more likely to do so in certain segments of
Featured image for “Measuring and tracking the alpha of private market funds”

Measuring and tracking the alpha of private market funds

Sep. 19, 2024
Scientific Infra & Private Assets is pleased to present an approach using privateMetrics® data to measure and track the alpha of private market funds, allowing robust and representative fund selection and monitoring. infraMetrics® & privateMetrics® provide access to hundreds of benchmarks across the infrastructure and private equity asset classes, enabling investors to create the most representative benchmark for the fund
Featured image for “Q2 2024 infra300® Release: Implications for Infrastructure Revenues of Economic Slowdown and Political Uncertainty”

Q2 2024 infra300® Release: Implications for Infrastructure Revenues of Economic Slowdown and Political Uncertainty

Jul. 18, 2024
The Infra300® Equity Index is a comprehensive global index representing the monthly total return of 300 unlisted infrastructure companies. This ESMA-registered market benchmark for private infrastructure investments is meticulously designed to provide an accurate reflection of the performance of the unlisted infrastructure sector by tracking various TICCS® segments, ensuring a broad and detailed representation of the unlisted infrastructure universe. Quarter-over-quarter,
Featured image for “NAV 2.0: A better asset pricing model for private infra”

NAV 2.0: A better asset pricing model for private infra

May. 02, 2024
CAPM may be ‘one of the founding frameworks of modern finance’, but for determining the net asset value of unlisted infrastructure it is terribly inadequate. Frédéric Blanc-Brude, the director of the EDHEC Infrastructure Institute explains why and offers an alternative. Originally published in Infrastructure Investor. When reporting the NAV of unlisted assets like infrastructure using discounted cashflows, best practice consists